Hypnotherapy: Adoptive Cellular Therapy

773 Words2 Pages

Many parts and systems of the human body can be impacted by cancer. The system of blood that supplies oxygen and nutrients is one such area. Leukemia is cancer that starts in the tissue that forms blood. Most blood cells are formed in bone marrow called stem cells. Bone marrow is the soft jelly-like substance in the center of bones. Once the cell is mature, it develops into different types of blood cells, each type performs a specific task. These cells include erythrocytes also known as red blood cells and leukocytes also known as white blood cells. Leukocytes are potent infection fighters and they come in the form of B-cells, natural killer cells, helper T-cells, and cytotoxic-T cells. Adoptive cellular therapy is a treatment used to help …show more content…

B-cells make antibodies that attack antigens, T cells make cytokines and attack damaged or diseased cells, and natural killer (NK) cells detect and destroy damaged cells. Cytokines are used in immunotherapy to cause cancer cells to die or to stop creating new cells. Cytokine-induced killer (CIK) cells are a group of natural killer (NK) T-cells that come from a blood cell having a round nucleus; peripheral blood mononuclear cells (PBMC). These blood cells are an important element in the immune system to fight infection and adapt to intruders. PBMCs can be extracted and cultured in vitro from patients with cancer. Immune cells identify major histocompatibility complex (MHC) present on infected cell surfaces, generating cytokine release and eventually causing apoptosis. However, CIK cells have the ability to detect infected or malignant cells in the absence of antibodies and MHC, allowing for a quick immune reaction. This characteristic of CIK cells can be useful as therapy for cancer and viral …show more content…

Chemotherapy is a method given in which patients are given drugs to kill of cancerous cells. Radiation is another method in which a patient’s body is exposed to high-energy beams to kill cancerous cells. In the study to find an immunotherapy strategy for leukemia, researchers have found that the treatment of leukemia by chemotherapy has achieved success however the issue of minimal residual disease and drug resistance has not been resolved among hematologists. Minimal residual disease is when a small amount of cancer cells remain in the patient during or after treatment when there is no sign of disease. MRD is the major cause of relapse in cancer and leukemia. According to the study, “a high relapse rate due to MRD remains the leading cause of treatment failure and the main cause or mortality.” (Chen et

Open Document